Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
27.10
+0.10 (0.37%)
At close: Jan 13, 2026, 4:00 PM EST
27.10
0.00 (0.00%)
After-hours: Jan 13, 2026, 6:40 PM EST
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.29 billion as of January 13, 2026. Its market cap has increased by 91.29% in one year.
Market Cap
1.29B
Enterprise Value
790.46M
1-Year Change
91.29%
Ranking
Category
Stock Price
$27.10
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.29B, an increase of 114.77%. That is a compound annual growth rate of 61.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 1.29B | -11.01% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |